Prostate Cell News 10.45 November 29, 2019 | |
| |
TOP STORYA series of functional analyses in cell lines, patient samples, and xenograft models were performed to investigate the biological significance and clinical relevance of SPOP regulation of stress granule signaling in prostate cancer. [Mol Cancer] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Scientists explored the diagnostic and prognostic/aggressiveness capacity of GOAT in urine, as well as to interrogate its putative pathophysiological role in prostate cancer. In vitro and in vivo approaches were performed in response to the modulation of GOAT expression/activity in prostate cancer cells. [J Clin Med] Full Article SUMO3 Modification by PIAS1 Modulates Androgen Receptor Cellular Distribution and Stability Investigators assessed the potential effect of SUMO3 modification on androgen receptor intracellular localization by immunostaining in androgen receptor-negative prostate cancer DU145 cells, and detected the effect of PIAS1/SUMO3 overexpression on androgen receptor sumoylation related degradation. [Cell Commun Signal] Full Article SOX2 Has Dual Functions as a Regulator in the Progression of Neuroendocrine Prostate Cancer Enrichr analysis resulted in the identification of SRY-related HMG-box gene 2 (SOX2) as a potential repressor that caused a decrease in the expression of prostate adenocarcinoma specific genes in neuroendocrine prostate cancer. [Lab Invest] Abstract Researchers investigated the role of histone deubiquitinase MYSM1 in the pathogenesis of prostate cancer. Tissues and public datasets of prostate cancer were evaluated for MYSM1 levels. They explored the effects of MYSM1 on cell proliferation, senescence and viability both in vitro and in vivo. [Aging (Albany NY)] Abstract Scientists showed that small molecule inhibition of peroxisome proliferator-activated receptor gamma (PPARγ) decreased the growth of androgen receptor-positive and -negative prostate cancer cells in vitro and that T0070907, a potent PPARγ antagonist, significantly decreased the growth of human prostate cancer xenografts in nude mice. [Prostate] Abstract The authors investigated the antitumor mechanism of pollen polysaccharides from Chinese wolfberry (WPPs) in DU145 cells and a xenograft mice model. The results showed that WPPs decreased the levels of PI3K, AKT, p-AKT and Bcl-2 proteins, and increased expression of Bax, caspase-3 and caspase-9 in DU145 cells. [Int J Biol Macromol] Abstract The proliferation, migration and invasion of prostate cancer cells were assessed by CCK-8 and transwell assay. HIF-1α expression of osteoblasts and epithelial-mesenchymal transition markers of prostate cancer cells were examined by Western blot. [BMC Cancer] Full Article Researchers demonstrated that plasmacytoma variant translocation 1 (PVT1) exon 9 was significantly overexpressed in prostate cancer tissues in comparison to normal prostate tissues. [Genes (Basel)] Abstract Using chip-based microarray, scientists investigated global miRNA expression in human prostate cancer cells representing early-stage, advanced-stage and castration resistant prostate cancer in comparison with normal prostate epithelial cells. [PLoS One] Full Article Subscribe to one of our other 19 science newsletters such as Mammary Cell News & ESC & iPSC News. | |
| |
REVIEWSGiven that late-stage cancers often develop hormone insensitivity, scientists explore the strengths and pitfalls of targeting other transcription factors outside of the nuclear receptor superfamily such as the signal transducer and activator of transcription. [Cancers] Full Article Visit our reviews page to see a complete list of reviews in the prostate cell research field. | |
| |
INDUSTRY NEWSINHIBITOR Therapeutics, Inc. announced that the company has submitted an investigational new drug (IND) application to the FDA to seek clearance to initiate an IND-opening clinical study as a two-part, multi-center, randomized, double-blind, placebo-controlled, Phase IIb clinical trial. [INHIBITOR Therapeutics, Inc.] Press Release Anixa Biosciences Announces Genesis Research to Join Cchekâ„¢ Prostate Cancer Study Anixa Biosciences, Inc. announced the addition of Genesis Research, LLC to the ongoing Cchekâ„¢ prostate cancer detection study. Genesis Research joins a large and growing team of collaborators advancing Anixa’s Cchekâ„¢ artificial intelligence driven liquid biopsy technology toward commercialization. [Anixa Biosciences, Inc.] Press Release | |
| |
POLICY NEWSStark Party Differences in ‘Brexit Election’ Could Shape Future of UK Science When representatives of each party took to a stage last week at the Royal Society in London, they all promised increased funding and easier immigration for scientists. But Brexit loomed over the discussion, says Sarah Main, director of the Campaign for Science and Engineering, an advocacy group in London. [ScienceInsider] Editorial PhD Students in China Report Misery and Hope In a Nature survey, only 55 percent of the Chinese students who responded to the survey said that they were at least partially satisfied with their PhD experience. For the 5,630 respondents outside China, the satisfaction rate was 72 percent. [Nature News] Editorial Chinese Ministry Investigates Duplications in Papers by University President The Chinese education ministry is investigating scientific articles authored by high-profile immunologist and university president Cao Xuetao, following suggestions that dozens of papers contain potentially problematic images. Four journals also say they are examining papers from Cao. [Nature News] Editorial
| |
EVENTSNEW Advances in Liquid Biopsies Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESPostdoctoral Associate – Tumor Metastasis (UPMC Hillman Cancer Center) Postdoctoral Positions – Cancer Research (Max Delbrück Center for Molecular Medicine) Tenure-Track Faculty Scientist Position – Radiation Oncology (New York University) Postdoctoral Studentship – Genomics of Hereditary Prostate Cancer (University of Manchester) Postdoctoral Researcher – Prostate Tumor Microenvironment (NorthShore University Health System) Postdoctoral Researcher – Prostate Cancer (University of California, San Francisco) Assistant Professor – Biology of Genitourinary Cancers (University of Chicago) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Prostate Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|